Biogen to buy early-stage potential Alzheimer’s, Parkinson’s treatment from Pfizer
Under the deal, Pfizer will get $75 million upfront and will be eligible for $635 million in potential milestone payments
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.